NCT03818542 - A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

September 23, 2020

Study Completion Date

September 23, 2020

Conditions

Head and Neck Cancer

Interventions

DRUG

ABBV-181

intravenous infusion

DRUG

ABBV-368

intravenous infusion

DRUG

ABBV-927

intravenous infusion

DRUG

ABBV-927

intratumoral injection

Trial Locations (3)

MD Anderson Cancer Center /ID# 208749, Houston

Massachusetts General Hospital /ID# 207392, Boston

University of Michigan /ID# 210181, Ann Arbor